Blocking Folate Metabolism with Oral, Prophylactic Drugs Could Reduce Viral Replication in SARS-CoV-2 Infected Cells
By HospiMedica International staff writers Posted on 16 Mar 2021 |
![Illustration Illustration](https://globetechcdn.com/mobile_hospimedica/images/stories/articles/article_images/2021-03-16/SDD-2629B.jpg)
Illustration
Insight provided by a new study into how SARS-CoV-2 hijacks two key metabolic pathways to rapidly replicate in host cells suggest that blocking folate metabolism with oral, prophylactic drugs could reduce viral replication in the infected cells.
Investigators from the Brigham and Women’s Hospital (Boston, MA, USA), Massachusetts General Hospital (MGH; Boston, MA, USA), and the Broad Institute (Cambridge, MA, USA) who studied cultured cells shortly after infecting them with SARS-CoV-2 have gained more insight into the metabolic pathways co-opted by the virus. The findings highlight the potential therapeutic benefit of drugs such as methotrexate, which inhibit folate and one-carbon metabolic pathways appropriated by the virus.
When SARS-CoV-2, the virus that causes COVID-19, infects a human cell, it quickly begins to replicate by seizing the cell’s existing metabolic machinery. The infected cells churn out thousands of viral genomes and proteins while halting the production of their own resources. To identify which metabolic pathways to target, the researchers obtained samples of the virus and cultivated them in a highly protected facility called a BSL-3 laboratory.
In analyzing the amino acids and thousands of chemical metabolites produced by the cells, the researchers observed that infected cells had depleted stores of glucose and folate. They demonstrated that the SARS-CoV-2 virus diverts building blocks from glucose production to the assembly of purine bases, which are necessary for creating large amounts of viral RNA. Additionally, they found that the 1-carbon pathway used to metabolize folate was hyperactive, thus supplying the virus with more carbon groups for making bases for DNA and RNA.
Drugs that inhibit folate metabolism, like methotrexate, are often used to treat autoimmune conditions like arthritis and could be therapeutic candidates for COVID-19. Methotrexate is currently being assessed as a treatment for the inflammation that accompanies more advanced COVID-19 infections, but the researchers suggest that it could also be beneficial early on. Their study also found that it could offer a synergistic effect when administered with the anti-viral drug remdesivir. Methotrexate’s immune-suppressing properties could make its proper administration as a prophylactic challenging, however. Researchers would need to determine how to maximize the drug’s antiviral effects without significantly compromising a patient’s natural immune response. Still, the researchers have pointed out that oral antivirals are an important addition to an arsenal of therapies for COVID-19, serving both as an immediate treatment for infection as well as a defense against new variants and other coronaviruses.
“One of the things we’re lacking in this pandemic is a pill that can be taken orally, as a prophylactic agent, before someone is hospitalized or even before they’re infected,” said corresponding author Benjamin Gewurz, MD, PhD, of the Division of Infectious Diseases at the Brigham. “Monoclonal antibodies have a lot of promise but need to be given intravenously. Blocking the metabolism pathways that viruses rely on to replicate could be a new strategy for treating patients at an early timepoint.”
“We’re hoping that, ultimately, we can find a way of preventing viruses from using cells’ metabolism pathways to replicate themselves because that could limit the ability of viruses to evolve resistance,” added Gewurz. “We’re starting to see new viral variants, and we’re hoping that we can stay ahead of that - treating patients before the virus has the chance to make copies of itself that could become resistant to antibodies.”
Related Links:
Brigham and Women’s Hospital
Massachusetts General Hospital
Broad Institute
Investigators from the Brigham and Women’s Hospital (Boston, MA, USA), Massachusetts General Hospital (MGH; Boston, MA, USA), and the Broad Institute (Cambridge, MA, USA) who studied cultured cells shortly after infecting them with SARS-CoV-2 have gained more insight into the metabolic pathways co-opted by the virus. The findings highlight the potential therapeutic benefit of drugs such as methotrexate, which inhibit folate and one-carbon metabolic pathways appropriated by the virus.
When SARS-CoV-2, the virus that causes COVID-19, infects a human cell, it quickly begins to replicate by seizing the cell’s existing metabolic machinery. The infected cells churn out thousands of viral genomes and proteins while halting the production of their own resources. To identify which metabolic pathways to target, the researchers obtained samples of the virus and cultivated them in a highly protected facility called a BSL-3 laboratory.
In analyzing the amino acids and thousands of chemical metabolites produced by the cells, the researchers observed that infected cells had depleted stores of glucose and folate. They demonstrated that the SARS-CoV-2 virus diverts building blocks from glucose production to the assembly of purine bases, which are necessary for creating large amounts of viral RNA. Additionally, they found that the 1-carbon pathway used to metabolize folate was hyperactive, thus supplying the virus with more carbon groups for making bases for DNA and RNA.
Drugs that inhibit folate metabolism, like methotrexate, are often used to treat autoimmune conditions like arthritis and could be therapeutic candidates for COVID-19. Methotrexate is currently being assessed as a treatment for the inflammation that accompanies more advanced COVID-19 infections, but the researchers suggest that it could also be beneficial early on. Their study also found that it could offer a synergistic effect when administered with the anti-viral drug remdesivir. Methotrexate’s immune-suppressing properties could make its proper administration as a prophylactic challenging, however. Researchers would need to determine how to maximize the drug’s antiviral effects without significantly compromising a patient’s natural immune response. Still, the researchers have pointed out that oral antivirals are an important addition to an arsenal of therapies for COVID-19, serving both as an immediate treatment for infection as well as a defense against new variants and other coronaviruses.
“One of the things we’re lacking in this pandemic is a pill that can be taken orally, as a prophylactic agent, before someone is hospitalized or even before they’re infected,” said corresponding author Benjamin Gewurz, MD, PhD, of the Division of Infectious Diseases at the Brigham. “Monoclonal antibodies have a lot of promise but need to be given intravenously. Blocking the metabolism pathways that viruses rely on to replicate could be a new strategy for treating patients at an early timepoint.”
“We’re hoping that, ultimately, we can find a way of preventing viruses from using cells’ metabolism pathways to replicate themselves because that could limit the ability of viruses to evolve resistance,” added Gewurz. “We’re starting to see new viral variants, and we’re hoping that we can stay ahead of that - treating patients before the virus has the chance to make copies of itself that could become resistant to antibodies.”
Related Links:
Brigham and Women’s Hospital
Massachusetts General Hospital
Broad Institute
Latest COVID-19 News
- Low-Cost System Detects SARS-CoV-2 Virus in Hospital Air Using High-Tech Bubbles
- World's First Inhalable COVID-19 Vaccine Approved in China
- COVID-19 Vaccine Patch Fights SARS-CoV-2 Variants Better than Needles
- Blood Viscosity Testing Can Predict Risk of Death in Hospitalized COVID-19 Patients
- ‘Covid Computer’ Uses AI to Detect COVID-19 from Chest CT Scans
- MRI Lung-Imaging Technique Shows Cause of Long-COVID Symptoms
- Chest CT Scans of COVID-19 Patients Could Help Distinguish Between SARS-CoV-2 Variants
- Specialized MRI Detects Lung Abnormalities in Non-Hospitalized Long COVID Patients
- AI Algorithm Identifies Hospitalized Patients at Highest Risk of Dying From COVID-19
- Sweat Sensor Detects Key Biomarkers That Provide Early Warning of COVID-19 and Flu
- Study Assesses Impact of COVID-19 on Ventilation/Perfusion Scintigraphy
- CT Imaging Study Finds Vaccination Reduces Risk of COVID-19 Associated Pulmonary Embolism
- Third Day in Hospital a ‘Tipping Point’ in Severity of COVID-19 Pneumonia
- Longer Interval Between COVID-19 Vaccines Generates Up to Nine Times as Many Antibodies
- AI Model for Monitoring COVID-19 Predicts Mortality Within First 30 Days of Admission
- AI Predicts COVID Prognosis at Near-Expert Level Based Off CT Scans
Channels
Critical Care
view channel![Image: The °M Warmer portable blood & IV fluid warmer has received US FDA 510(k) regulatory clearance (Photo courtesy of °MEQU) Image: The °M Warmer portable blood & IV fluid warmer has received US FDA 510(k) regulatory clearance (Photo courtesy of °MEQU)](https://globetechcdn.com/mobile_hospimedica/images/stories/articles/article_images/2024-06-17/mequmwarmerandpowerpack.jpg)
Portable System for Warming Blood and IV-Fluids Reduces Hypothermia Risk in Hemorrhaging Patients
Maintaining a normothermic temperature in patients is often challenging. Accidental hypothermia is a known risk that can lead to increased complications and extended hospital stays. One key factor contributing... Read more![Image: Flow chart showing the study notification protocol (Photo courtesy of Mount Sinai Health System) Image: Flow chart showing the study notification protocol (Photo courtesy of Mount Sinai Health System)](https://globetechcdn.com/mobile_hospimedica/images/stories/articles/article_images/2024-06-17/Press-Release-AI.jpg)
AI-Generated Real-Time Alerts for Declining Health Speeds Up Treatment and Reduces Hospital Deaths
A fundamental objective of inpatient care is the timely intervention to prevent or manage clinical deterioration, which often leads to escalated care associated with poorer outcomes and increased use of resources.... Read more![Image: Researchers have made significant advances in ingestible microbiome sampling pill technology (Photo courtesy of Tufts University) Image: Researchers have made significant advances in ingestible microbiome sampling pill technology (Photo courtesy of Tufts University)](https://globetechcdn.com/mobile_hospimedica/images/stories/articles/article_images/2024-06-14/news-2406-ingestible-pill.jpg)
Ingestible Microbiome Sampling Pill to Help Diagnose Wide Range of Health Conditions
The healthy human gut is home to more than 1,000 species of bacteria, most of which play a beneficial role in digestion and protecting against disease. When the natural balance of these microbes is disrupted,... Read moreSurgical Techniques
view channel![Image: New studies suggest benefit of total robotic metabolic and bariatric surgery over conventional laparoscopy (Photo courtesy of 123RF) Image: New studies suggest benefit of total robotic metabolic and bariatric surgery over conventional laparoscopy (Photo courtesy of 123RF)](https://globetechcdn.com/mobile_hospimedica/images/stories/articles/article_images/2024-06-13/143615440_m_normal_none.jpg)
Total Robotic Metabolic and Bariatric Surgery Proves More Beneficial than Conventional Laparoscopy
According to the U.S. Centers for Disease Control and Prevention (CDC), 42.4% of Americans are affected by obesity. Research indicates that obesity can compromise the immune system, trigger chronic inflammation,... Read more![Image: Concept of the wirelessly actuated undulating pump and its integration into an esophageal stent (Photo courtesy of Advanced Functional Materials/ doi.org/10.1002/adfm.202405865) Image: Concept of the wirelessly actuated undulating pump and its integration into an esophageal stent (Photo courtesy of Advanced Functional Materials/ doi.org/10.1002/adfm.202405865)](https://globetechcdn.com/mobile_hospimedica/images/stories/articles/article_images/2024-06-11/adfm202405865-fig-0001-m.jpg)
Wirelessly Activated Robotic Device Aids Digestion in Patients with Compromised Organs
The transport of fluids and solids is essential in the human body, driven by a wave-like movement in the lumen known as peristalsis. However, peristalsis can be disrupted in patients who have obstructions... Read morePatient Care
view channel![Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners) Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)](https://globetechcdn.com/mobile_hospimedica/images/stories/articles/article_images/2024-05-01/Freestyle_1.jpg)
First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more![Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu) Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)](https://globetechcdn.com/mobile_hospimedica/images/stories/articles/article_images/2023-09-26/SDD-294798729.jpg)
Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization
An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more![Image: The Instrument Pod is clinically proven to make the OR and sterile processing more efficient (Photo courtesy of Turbett Surgical) Image: The Instrument Pod is clinically proven to make the OR and sterile processing more efficient (Photo courtesy of Turbett Surgical)](https://globetechcdn.com/mobile_hospimedica/images/stories/articles/article_images/2023-07-13/SDD-294797885.jpg)
Game-Changing Innovation in Surgical Instrument Sterilization Significantly Improves OR Throughput
A groundbreaking innovation enables hospitals to significantly improve instrument processing time and throughput in operating rooms (ORs) and sterile processing departments. Turbett Surgical, Inc.... Read moreHealth IT
view channel![Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai) Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)](https://globetechcdn.com/mobile_hospimedica/images/stories/articles/article_images/2023-05-26/SDD-294797344.jpg)
Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients
Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more![Image: Integration of generative AI into healthcare can increase productivity and enhance patient care (Photo courtesy of Microsoft) Image: Integration of generative AI into healthcare can increase productivity and enhance patient care (Photo courtesy of Microsoft)](https://globetechcdn.com/mobile_hospimedica/images/stories/articles/article_images/2023-05-16/SDD-294797200.jpg)
Strategic Collaboration to Develop and Integrate Generative AI into Healthcare
Top industry experts have underscored the immediate requirement for healthcare systems and hospitals to respond to severe cost and margin pressures. Close to half of U.S. hospitals ended 2022 in the red... Read more![Image: iQueue for Operating Rooms maximizes OR access by optimizing block and open time (Photo courtesy of Freepik) Image: iQueue for Operating Rooms maximizes OR access by optimizing block and open time (Photo courtesy of Freepik)](https://globetechcdn.com/mobile_hospimedica/images/stories/articles/article_images/2023-05-10/SDD-294797132.jpg)
AI-Enabled Operating Rooms Solution Helps Hospitals Maximize Utilization and Unlock Capacity
For healthcare organizations, optimizing operating room (OR) utilization during prime time hours is a complex challenge. Surgeons and clinics face difficulties in finding available slots for booking cases,... Read more![Image: AI model spots those at highest risk for up to three years before diagnosis (Photo courtesy of Freepik) Image: AI model spots those at highest risk for up to three years before diagnosis (Photo courtesy of Freepik)](https://globetechcdn.com/mobile_hospimedica/images/stories/articles/article_images/2023-05-10/SDD-294797117.jpg)
AI Predicts Pancreatic Cancer Three Years before Diagnosis from Patients’ Medical Records
Screening for common cancers like breast, cervix, and prostate cancer relies on relatively simple and highly effective techniques, such as mammograms, Pap smears, and blood tests. These methods have revolutionized... Read morePoint of Care
view channel![Image: POCT offers cost-effective, accessible, and immediate diagnostic solutions (Photo courtesy of Flinders University) Image: POCT offers cost-effective, accessible, and immediate diagnostic solutions (Photo courtesy of Flinders University)](https://globetechcdn.com/mobile_hospimedica/images/stories/articles/article_images/2024-05-30/28897_about_up_woman_operating_poct_machine.jpg)
POCT for Infectious Diseases Delivers Laboratory Equivalent Pathology Results
On-site pathology tests for infectious diseases in rural and remote locations can achieve the same level of reliability and accuracy as those conducted in hospital laboratories, a recent study suggests.... Read more![Image: The cartridge-based TEG 6s system provides clinicians a complete picture about a patient\'s coagulation profile (Photo courtesy of Haemonetics Corporation) Image: The cartridge-based TEG 6s system provides clinicians a complete picture about a patient\'s coagulation profile (Photo courtesy of Haemonetics Corporation)](https://globetechcdn.com/mobile_hospimedica/images/stories/articles/article_images/2024-05-28/TEG6s-5-Hospital-Single-Product-Image-429x429-Recovered.jpg)
Cartridge-Based Hemostasis Analyzer System Enables Faster Coagulation Testing
Quickly assessing a patient's total hemostasis status can be critical to influencing clinical outcomes and using blood products. Haemonetics Corporation (Boston, MA, USA) has now obtained 510(k) clearance... Read more![Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics) Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)](https://globetechcdn.com/mobile_hospimedica/images/stories/articles/article_images/2024-04-05/Quantra_Instrument_QStat_Dials_2022.jpg)
Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing
Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read moreBusiness
view channel![Image: The Critical Care acquisition will enhance BD’s portfolio of smart connected care solutions (Photo courtesy of BD) Image: The Critical Care acquisition will enhance BD’s portfolio of smart connected care solutions (Photo courtesy of BD)](https://globetechcdn.com/mobile_hospimedica/images/stories/articles/article_images/2024-06-04/Hemodynamic_Monitoring_1.jpg)
BD Acquires Edwards Lifesciences' Critical Care Product Group for USD 4.2 Billion
BD (Becton, Dickinson and Company, Franklin Lakes, NJ, USA) and Edwards Lifesciences (Irvine, CA, USA) have entered into a definitive agreement under which BD will acquire Edwards' Critical Care product... Read more![Image: The MEDICA START-UP PARK is the meeting place for networking for and with the creative start-up scene (Photo courtesy of Constanze Tillmann/Messe Düsseldorf) Image: The MEDICA START-UP PARK is the meeting place for networking for and with the creative start-up scene (Photo courtesy of Constanze Tillmann/Messe Düsseldorf)](https://globetechcdn.com/mobile_hospimedica/images/stories/articles/article_images/2024-05-30/MEDICA23_STARTUP_PARK.jpg)